Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

826 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-01

Study Completion Date

2024-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to analyze perioperative information in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing total hysterectomy (TH), offering insights into optimal surgery timing, selecting the operation path, and enhancing surgical operation details.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Laparoscopic Radical Hysterectomy Based on Space Anatomy in Patients With IB3 and IIA2 Cervical Cancer

NCT06759480

Locally Advanced Cervical Cancer

NOT_YET_RECRUITING

The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer

NCT01893333

Cervical Cancer

UNKNOWN NA

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

NCT07120529

Cervical Cancer Hysterectomy

RECRUITING

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1)

NCT04929769

Cervical Cancer

RECRUITING NA

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)

NCT04934982

Cervical Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High-Grade Squamous Intraepithelial Lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

patients underwent laparoscopic hysterectomy within 3 days after LEEP

surgical timing and operation path

Intervention Type PROCEDURE

surgical timing; laparoscopic hysterectomy or abdominal hysterectomy

group 2

patients underwent abdominal hysterectomy within 3 days after LEEP

surgical timing and operation path

Intervention Type PROCEDURE

surgical timing; laparoscopic hysterectomy or abdominal hysterectomy

group 3

patients underwent laparoscopic hysterectomy 4 weeks after LEEP

surgical timing and operation path

Intervention Type PROCEDURE

surgical timing; laparoscopic hysterectomy or abdominal hysterectomy

group 4

underwent abdominal hysterectomy 4 weeks after LEEP

surgical timing and operation path

Intervention Type PROCEDURE

surgical timing; laparoscopic hysterectomy or abdominal hysterectomy

control group

Patients who underwent laparoscopic hysterectomy (LH) due to benign gynecological diseases were included in the control group.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgical timing and operation path

surgical timing; laparoscopic hysterectomy or abdominal hysterectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients were confirmed with HSIL through pathology at our hospital or another tertiary facility, with additional confirmation via pathological consultation at our facility;
* LH or abdominal hysterectomy (AH) +/- bilateral fallopian tube or bilateral adnexectomy was performed after LEEP;
* the patient had no history of systemic malignancies.

Exclusion Criteria

* severe medical and surgical complications;
* an extensive or subextensive hysterectomy was performed;
* surgical removal scope involving tissues (such as lymph nodes) or organs (such as the appendix) other than the uterus, ovaries, and fallopian tubes;
* fever symptoms within the last month;
* incidence of pelvic and abdominal infections, vaginitis, or similar conditions within the past month.

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No